ChemImpex Fingolimod hydrochloride; 98% (Assay by titration , HPLC); 162359-56-0; MFCD00939512, 200MG

Fingolimod hydrochloride is a potent immunomodulatory agent primarily used in the treatment of multiple sclerosis (MS). This compound functions by modulating sphingosine-1-phosphate (S1P) receptors, effectively sequestering lymphocytes in lymph nodes and preventing their migration to the central nervous system. This mechanism not only reduces the frequency of MS flare-ups but also helps in managing the progression of the disease. Fingolimod hydrochloride has gained recognition for its oral bioavailability, offering a convenient alternative to traditional injectable therapies, thus enhancing patient compliance and quality of life.

In addition to its primary application in MS, Fingolimod hydrochloride is being explored for potential uses in other autoimmune diseases and transplant rejection scenarios due to its immunosuppressive properties. Researchers are investigating its role in conditions such as psoriasis and Crohns disease, highlighting its versatility in therapeutic applications. The compounds unique ability to cross the blood-brain barrier further underscores its significance in neurological research, making it a valuable asset for professionals in the pharmaceutical and biomedical fields.

Specifications

Safety & Regulations